glp-1 and ghrelin Targeting GLP-1, GIP & GCG

Morton points to retatrutide, a weekly injection from Eli Lilly currently in clinical development for obesity and type 2 diabetes, as an example

Telehealth platforms have made prescriptions easier to get, compounding pharmacies temporarily filled in supply gaps during shortages, and by late 2025 the FDA approved the first once-daily oral GLP-1 pill that doesn't require food or water restrictions a major convenience upgrade over weekly injections

The supporting studies clearly show that apnea symptoms are reduced because of lower body weight

Instead of focusing on restriction or perfection, aim for nutrient-dense meals that fuel your body, keep you full and energized, and fit into your real life